hemophilia


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to hemophilia: hemophilia B

he·mo·phil·i·a

 (hē′mə-fĭl′ē-ə, -fēl′yə)
n.
Any of several sex-linked genetic disorders, manifested almost exclusively in males, in which the blood fails to clot normally because of a deficiency or an abnormality of one of the clotting factors.

he•mo•phil•i•a

(ˌhi məˈfɪl i ə)

n.
any of several X-linked genetic disorders, symptomatic chiefly in males, in which excessive bleeding occurs from minor injuries owing to the absence or abnormality of a clotting factor in the blood.
[1850–55; < German Hämophilie (1828); see hemo-, -philia]

he·mo·phil·i·a

(hē′mə-fĭl′ē-ə)
An inherited disease in which the blood does not clot properly, causing excessive bleeding. Hemophilia usually only affects males.

hemophilia, haemophilia

a tendency to uncontrolled bleeding. Also hemorrhaphilia, haemorrhaphilia. — hemophiliac, haemophiliac, n., adj.
See also: Blood and Blood Vessels
an hereditary tendency, in males, toward a deficiency in coagulation factors in the blood. — hemophiliac, haemophiliac, n., adj.
See also: Disease and Illness

hemophilia

An inherited disorder of males passed on by females, in which the absence of a clotting factor in the blood means that bleeding becomes hard to stop.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.hemophilia - congenital tendency to uncontrolled bleedinghemophilia - congenital tendency to uncontrolled bleeding; usually affects males and is transmitted from mother to son
classical haemophilia, classical hemophilia, haemophilia A, hemophilia A - hemophilia caused by a congenital deficiency of factor VIII; occurs almost exclusively in men
Christmas disease, haemophilia B, hemophilia B - a clotting disorder similar to hemophilia A but caused by a congenital deficiency of factor IX
angiohemophilia, vascular hemophilia, von Willebrand's disease - a form of hemophilia discovered by Erik von Willebrand; a genetic disorder that is inherited as an autosomal recessive trait; characterized by a deficiency of the coagulation factor and by mucosal bleeding
blood disease, blood disorder - a disease or disorder of the blood
sex-linked disorder - any disease or abnormality that is determined by the sex hormones; "hemophilia is determined by a gene defect on an X chromosome"
Translations

he·mo·phil·i·a

n. hemofilia, condición hereditaria caracterizada por deficiencia de coagulación y tendencia a sangrar.

hemophilia

n hemofilia
References in periodicals archive ?
Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders.
Hemophilia is a lifelong disease causing significant morbidity and mortality.
Arthropathy was the most frequently developing complication in patients 10 (100%) of severe Hemophilia B.
Summary: The Lebanese Association of Hemophilia said Wednesday that it has uncovered 332 cases of hemophilia sickness up to the end of 2011.
Objective: This study aimed to investigate the association between HLA class II alleles and the occurrence of FVIII inhibitor in Thai hemophilia A patients.
Medical News TODAY reported that Baxter International launched "Our Lives with Hemophilia: The Stories of Vaibhav and Paul" at the Hemophilia 2010 World Congress of the World Federation of Hemophilia (WFH), July 2010.
Chronic synovitis and HLA B27 in patients with severe hemophilia.
Bayer HealthCare is expanding its commitment to hemophilia with the acquisition of Maxygen's hemophilia program assets, including a next-generation recombinant Factor VIIa protein known as MAXY-VII.
This article discusses trends in health care that affect hemophilia social work practice in terms of clinical roles and macro interventions.
People with severe hemophilia live in fear of cuts and bruises, which bleed profusely and require prompt injections of expensive medication.
a medical products maker, said Thursday that it won regulatory approval for a second production unit at its plant that produces a genetically engineered hemophilia therapy.
According to the National Hemophilia Foundation (1998), there are approximately 22,865 people with some form of hemophilia in the United States, including 12,271 children under 19 years old.